Copyright
©The Author(s) 2020.
World J Clin Cases. Nov 6, 2020; 8(21): 5353-5360
Published online Nov 6, 2020. doi: 10.12998/wjcc.v8.i21.5353
Published online Nov 6, 2020. doi: 10.12998/wjcc.v8.i21.5353
Test items | Patient 1 before placement | Patient 1 after placement | Patient 2 before placement | Patient 2 after placement |
WBC | 11.32 × 109/L | 7.46 × 109/L | 7.33 × 109/L | 3.29 × 109/L |
NEUT% | 83.2% | 60.2% | 74.1% | 52.6% |
HGB | 93 g/L | 111 g/L | 127 g/L | 132 g/L |
PLT | 287 × 109/L | 189 × 109/L | 224 × 109/L | 173 × 109/L |
ALP | 200.3 U/L | 150.4 U/L | 34.2 U/L | 33.2 U/L |
ALT | 71.2 U/L | 48.2 U/L | 30.1 U/L | 31 U/L |
T-BIL | 82.78 μmol/L | 18.12 μmol/L | 10.25 μmol/L | 9.73 μmol/L |
D-BIL | 78.08 μmol/L | 13.29 μmol/L | 4.16 μmol/L | 3.92 μmol/L |
TP | 60.7 g/L | 68.2 g/L | 61.2 g/L | 66.0 g/L |
ALB | 29.5 g/L | 41.4 g/L | 40.3 g/L | 45.2 g/L |
- Citation: Hu HT, Ma FH, Wu ZM, Qi XH, Zhong YX, Xie YB, Tian YT. Treatment of afferent loop syndrome using fluoroscopic-guided nasointestinal tube placement: Two case reports. World J Clin Cases 2020; 8(21): 5353-5360
- URL: https://www.wjgnet.com/2307-8960/full/v8/i21/5353.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i21.5353